Tarsons Products Limited (NSE:TARSONS)
341.70
+10.05 (3.03%)
Oct 7, 2026, 3:30 PM IST
Tarsons Products Revenue
Tarsons Products had revenue of 1.10B INR in the quarter ending June 30, 2026, with 20.66% growth. This brings the company's revenue in the last twelve months to 4.41B, up 10.63% year-over-year. In the fiscal year ending March 31, 2026, Tarsons Products had annual revenue of 4.23B with 7.67% growth. That makes Tarsons Products the world's 28,576th largest company by revenue and 1,866th in India.
Revenue (ttm)
4.41B
Revenue Growth
+10.63%
P/S Ratio
4.12
Revenue / Employee
3.98M
Employees
1,108
Market Cap
18.18B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.23B | 300.99M | 7.67% |
| Mar 31, 2025 | 3.92B | 960.20M | 32.40% |
| Mar 31, 2024 | 2.96B | 131.46M | 4.64% |
| Mar 31, 2023 | 2.83B | -175.46M | -5.83% |
| Mar 31, 2022 | 3.01B | 694.77M | 30.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Zydus Lifesciences | 285.92B |
| Divi's Laboratories | 112.30B |
| Lenskart Solutions | 96.34B |
| Krsnaa Diagnostics | 8.41B |
| Beta Drugs | 4.10B |
| Accent Microcell | 3.50B |
| Suraksha Diagnostic | 3.25B |